Shanghai MicroPort MedBot Group Co Ltd

2252.HK | Healthcare | HKSE
$25.28
-1.84 (-6.78%)

Key Metrics

Market Cap
$25.91B
P/E Ratio
-51.59
EPS
$-0.49
Beta
N/A
Dividend Yield
N/A
ROE
-117.69%
Current Ratio
1.69

Company Information

Industry
Medical Devices

About Shanghai MicroPort MedBot Group Co Ltd

Shanghai Microport Medbot Group Co Ltd engages in the research and development design manufacture and sale of surgical robots in the Peoples Republic of China and Europe It offers Toumai a laparoscopic surgical robot for use in urologic gynecologic thoracic and general surgeries DFVision a 3D electronic laparoscope which is used in laparoscopic surgeries for abdominal thoracic and pelvic organs Honghu an orthopedic surgical robot for knee arthroplasty and hip arthroplasty ROne a vascular interventional surgical robot for coronary angioplasty and iSRobot a Mona Lisa robotic transperineal prostate biopsy system The company also provides spine surgical robots transbronchial surgical robots for transbronchial diagnosis and treatment TAVR surgical robots for heart valve replacement surgery and automated needle targeting robotics systems for percutaneous lung biopsy and percutaneous nephrolithotomy Shanghai Microport Medbot Group Co Ltd was founded in 2014 and is based in Shanghai China Shanghai Microport Medbot Group Co Ltd operates as a subsidiary of MicroPort Scientific Corporation

Financial Ratios (TTM)

Gross Margin
33.18%
Operating Margin
-106.37%
Net Margin
-143.42%
ROA
-31.91%
Price to Book
45.59
Price to Sales
72.64